Your browser doesn't support javascript.
loading
A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease.
Olanow, C Warren; Hauser, Robert A; Burdick, Daniel J; Dhall, Rohit; de Marcaida, Joy Antonelle; Gil, Ramon A; Kreitzman, David L; Elmer, Lawrence W; McGarry, Andrew; Kieburtz, Karl.
Afiliação
  • Olanow CW; Departments of Neurology and Department of Neuroscience, Mount Sinai School of Medicine, New York, New York, USA.
  • Hauser RA; Clintrex Research Corporation, Sarasota, Florida, USA.
  • Burdick DJ; Department of Neurology, Parkinson Foundation Center of Excellence, University of South Florida, Tampa, Florida, USA.
  • Dhall R; Booth Gardner Parkinson's Care Center, Eastside Neuroscience Institute, Evergreen Health Medical Center, Kirkland, WA, USA.
  • de Marcaida JA; University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Gil RA; Hartford HealthCare Chase Family Movement Disorders Center, Vernon, Connecticut, USA.
  • Kreitzman DL; Hartford HealthCare Chase Family Movement Disorders Center, Vernon, Connecticut, USA.
  • Elmer LW; Parkinson's Disease Treatment Center of SW Florida, Naples, Florida, USA.
  • McGarry A; Movement Disorders Center of Long Island, Commack, New York, USA.
  • Kieburtz K; Department of Neurology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
Mov Disord ; 39(2): 350-359, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37886872
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Indanos Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Indanos Idioma: En Ano de publicação: 2024 Tipo de documento: Article